NDC 63323-885 – Levothyroxine Sodium
Levothyroxine Sodium 20 ug/mL · Injection, Solution · Intravenous
Product NDC63323-885
Product details
- Brand name
- Levothyroxine Sodium
- Generic name
- Levothyroxine Sodium
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA210632
- Marketed since
- May 29, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- l-Thyroxine
Active ingredients
- Levothyroxine Sodium 20 ug/mL
Uses, dosage, side effects and warnings for Levothyroxine Sodium →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 63323-885-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-10) / 5 mL in 1 VIAL, SINGLE-DOSE | May 29, 2018 |
| 63323-885-12 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-12) / 5 mL in 1 VIAL, SINGLE-DOSE | May 29, 2018 |
| 63323-885-14 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-14) / 5 mL in 1 VIAL, SINGLE-DOSE | May 29, 2018 |
Other Levothyroxine Sodium products
- 63323-890 Levothyroxine Sodium 40 ug/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 63323-895 Levothyroxine Sodium 100 ug/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 24201-002 Levothyroxine Sodium 100 ug/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 50090-4799 Levothyroxine Sodium 125 ug/1 · Tablet · A-S Medication Solutions
- 50090-5654 Levothyroxine Sodium 100 ug/1 · Tablet · A-S Medication Solutions
- 50090-6101 Levothyroxine Sodium 100 ug/1 · Tablet · A-S Medication Solutions
- 50090-4951 Levothyroxine Sodium .088 mg/1 · Tablet · A-S Medication Solutions
- 50090-6103 Levothyroxine Sodium 112 ug/1 · Tablet · A-S Medication Solutions
- 50090-5792 Levothyroxine Sodium .137 mg/1 · Tablet · A-S Medication Solutions
- 50090-6089 Levothyroxine Sodium 137 ug/1 · Tablet · A-S Medication Solutions
- 50090-6100 Levothyroxine Sodium 125 ug/1 · Tablet · A-S Medication Solutions
- 50090-6090 Levothyroxine Sodium 50 ug/1 · Tablet · A-S Medication Solutions